Jenny Valladeau‐Guilemond

Author

Also Known As

J. Valladeau-Guilemond, Jenny Valladeau-Guilemond, Jenny Valladeau‐Guilemond, Jenny valladeau-guilemond, Nathalie Bendriss-Vermare, Valladeau-Guilemond, Jenny

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre de Recherche en Cancérologie de Lyon Centre Léon Bérard Centre National de la Recherche Scientifique Université Claude Bernard Lyon 1

About

Jenny Valladeau‐Guilemond is an author at Inserm specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	239
2	Cell Biology	3	3	224
3	Immunology	3	3	224
4	Engineering	1	1	32
5	Biomedical Engineering	1	1	32

Jenny Valladeau‐Guilemond

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Characterization of resident and migratory dendritic cells in human lymph nodes Élodie Segura, Jenny Valladeau‐Guilemond, Marie‐Hélène Donnadieu, The Journal of Experimental Medicine	2012	309
Development of NK cell-based cancer immunotherapies through receptor engineering Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond, Cellular and Molecular Immunology	2024	164
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer Margaux Hubert, Élisa Gobbini, Coline Couillault, Science Immunology	2020	136
Human XCR1+ Dendritic Cells Derived In Vitro from CD34+ Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells Sreekumar Balan, Vincent Ollion, Nicholas Colletti, The Journal of Immunology Blood DcDc ExcelImmunologyPathologyImmunologic Mechanism	2014	126
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy Paola Bonaventura, Vincent Alcazer, Virginie Mutez, Science Advances	2022	94
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage Colette Dezutter‐Dambuyant, Isabelle Durand, Laurent Alberti, OncoImmunology	2015	93
Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay Estelle Verronèse, Ana Sofia Delgado, Jenny Valladeau‐Guilemond, OncoImmunology	2015	74
Human natural killer cells promote cross‐presentation of tumor cell‐derived antigens by dendritic cells Florence Deauvieau, Vincent Ollion, Anne‐Claire Doffin, International Journal of Cancer Adaptive Immune SystemImmunologyImmune RegulationNk CellsImmunologic Mechanism	2014	66
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 <sup>+</sup> and CD8 <sup>+</sup> T‐cell protective responses to breast cancer Raphaël Mattiuz, Carine Brousse, Marc Ambrosini, Clinical & Translational Immunology	2021	54
Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC P Giroud, Sarah Renaudineau, Laura Gudefin, Frontiers in Immunology	2020	39

Page 1